4AKN | pdb_00004akn

N-Terminal Bromodomain of Human BRD2 With tbutyl-phenyl-amino- dimethyl-oxazolyl-quinoline-carboxylic acid


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.82 Å
  • R-Value Free: 
    0.197 (Depositor), 0.207 (DCC) 
  • R-Value Work: 
    0.168 (Depositor), 0.176 (DCC) 
  • R-Value Observed: 
    0.170 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 4AKN

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Identification of a Novel Series of Bet Family Bromodomain Inhibitors: Binding Mode and Profile of I-Bet151 (Gsk1210151A).

Seal, J.Lamotte, Y.Donche, F.Bouillot, A.Mirguet, O.Gellibert, F.Nicodeme, E.Krysa, G.Kirilovsky, J.Beinke, S.Mccleary, S.Rioja, I.Bamborough, P.Chung, C.Gordon, L.Lewis, T.Walker, A.L.Cutler, L.Lugo, D.Wilson, D.M.Witherington, J.Lee, K.Prinjha, R.K.

(2012) Bioorg Med Chem Lett 22: 2968

  • DOI: https://doi.org/10.1016/j.bmcl.2012.02.041
  • Primary Citation Related Structures: 
    4AKN, 4ALG

  • PubMed Abstract: 

    A novel series of quinoline isoxazole BET family bromodomain inhibitors are discussed. Crystallography is used to illustrate binding modes and rationalize their SAR. One member, I-BET151 (GSK1210151A), shows good oral bioavailability in both the rat and minipig as well as demonstrating efficient suppression of bacterial induced inflammation and sepsis in a murine in vivo endotoxaemia model.


  • Organizational Affiliation
    • Epinova DPU, GlaxoSmithKline R&D, Medicines Research Centre, Stevenage, Hertfordshire, UK. jon.t.seal@gsk.com

Macromolecule Content 

  • Total Structure Weight: 54.6 kDa 
  • Atom Count: 3,282 
  • Modeled Residue Count: 330 
  • Deposited Residue Count: 459 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
BROMODOMAIN-CONTAINING PROTEIN 2
A, B, C
153Homo sapiensMutation(s): 0 
UniProt & NIH Common Fund Data Resources
Find proteins for P25440 (Homo sapiens)
Explore P25440 
Go to UniProtKB:  P25440
PHAROS:  P25440
GTEx:  ENSG00000204256 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP25440
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 4 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
S5B

Query on S5B



Download:Ideal Coordinates CCD File
E [auth A],
H [auth B]
4-[(2-tert-butylphenyl)amino]-7-(3,5-dimethyl-1,2-oxazol-4-yl)quinoline-3-carboxylic acid
C25 H25 N3 O3
OWUQUQCSBQATFQ-UHFFFAOYSA-N
SO4

Query on SO4



Download:Ideal Coordinates CCD File
F [auth A],
G [auth A],
J [auth C]
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
DMS

Query on DMS



Download:Ideal Coordinates CCD File
I [auth C]DIMETHYL SULFOXIDE
C2 H6 O S
IAZDPXIOMUYVGZ-UHFFFAOYSA-N
EDO

Query on EDO



Download:Ideal Coordinates CCD File
D [auth A]1,2-ETHANEDIOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.82 Å
  • R-Value Free:  0.197 (Depositor), 0.207 (DCC) 
  • R-Value Work:  0.168 (Depositor), 0.176 (DCC) 
  • R-Value Observed: 0.170 (Depositor) 
Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 114.314α = 90
b = 55.73β = 94.34
c = 67.991γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
HKL-2000data reduction
SCALEPACKdata scaling

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2012-07-04
    Type: Initial release
  • Version 1.1: 2012-11-14
    Changes: Database references
  • Version 1.2: 2019-05-15
    Changes: Advisory, Data collection, Experimental preparation, Other
  • Version 1.3: 2024-05-08
    Changes: Advisory, Data collection, Database references, Derived calculations, Other